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Abstract: Carbohydrate-based vaccines are among the safest
and most effective vaccines and represent potent tools for
prevention of life-threatening bacterial infectious diseases, like
meningitis and pneumonia. The chemical conjugation of
a weak antigen to protein as a source of T-cell epitopes
generates a glycoconjugate vaccine that results more immuno-
genic. Several methods have been used so far to characterize
the resulting polysaccharide–protein conjugates. However,
a reduced number of methodologies has been proposed for
measuring the degree of saccharide conjugation at the possible
protein sites. Here we show that detailed information on large
proteins conjugated with large polysaccharides can be achieved
by a combination of solution and solid-state NMR spectros-
copy. As a test case, a large protein assembly, l-asparaginase
II, has been conjugated with Neisseria meningitidis serogroup
C capsular polysaccharide and the pattern and degree of
conjugation were determined.
Encapsulated bacteria, such as Neisseria meningitidis, Strep-
toccoccus pneumoniae and Haemophilus influenzae, have
polysaccharides on their exterior.[1] The capsular polysaccha-
rides protect the microorganism from adverse environmental
conditions, prevent the activation of the host immune system
and improve adhesion to invade the host.[2–4] Capsular
polysaccharides of pathogens have been used to produce
vaccines that are effective in adults,[5,6] but result ineffective in
children below 2 years of age:[7–9] being T-cell-independent
antigens, they do not induce B-cell memory and do not
stimulate the production of immunoglobulin G (IgG). How-
ever, a T-cell-dependent response (thus inducing B-cell
memory) can be obtained by chemical coupling of polysac-
charides to immunogenic proteins. Polysaccharide–protein
conjugates are commonly obtained by covalent linkage of
reactive precursors to the e-amino groups of surface-exposed
lysine residues or other reactive amino acids.[10] This con-
jugation strategy may lead to a highly random derivatization:
the protein can be glycosylated at different sites and to
different extents at each site (conjugation pattern); this in
turn leads to a polydispersity in the resulting protein
conjugates (Figure 1). To overcome this limitation, dedicated
synthetic strategies are being developed.[11]
Together with the conjugation pattern of the polysaccha-
ride, the preservation of the native protein structure may
influence the immunogenicity and efficacy of the glycoconju-
gate vaccines.[12–14] Therefore, the structural characterization
of the protein component, the identification of the conjuga-
tion sites, and the evaluation of the conjugation degree at
different lysine sites are a compelling requirement towards
structure-based development[15–18] of glycoconjugate vaccines.
The presence of polysaccharide chains prevents the crystal-
lization of the protein conjugates, and extends the molecular
weight of the system beyond the limits of solution NMR
spectroscopy,[19] similarly to what happens upon PEGyla-
tion.[20–22] Solution NMR spectroscopy is currently used to
characterize both the polysaccharide[23,24] and the protein
components separately before the conjugation.[25] Several
solution-based analytical methods have been used so far to
characterize the polysaccharide–protein conjugates.[13,26, 27]
SDS-PAGE and HPLC-SEC are often used to determine
the size and hydrodynamic volume of the conjugates, and to
estimate the number, but not the position, of the polysaccha-
ride chains covalently bound to the protein. Also small-angle
X-ray/neutron scattering and light scattering provide infor-
mation on the size and shape of the coated proteins, but
cannot map the conjugation sites.[28, 29] More detailed infor-
mation on the conjugation sites along the primary sequence of
the protein can be achieved by mass spectrometry.[27] How-
ever, also for mass spectrometry the evaluation of the
conjugation degree at the different sites in polydisperse
populations of isomers is a challenge. Recently, we have
shown that structural information on large PEGylated
proteins, such as E. coli l-Asparaginase-II (138 kDa,
ANSII, see the Supporting Information), can be obtained
by solid-state NMR spectroscopy.[30] Several excellent reports
on capsular polysaccharides, bacterial cell walls and their
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maturation have been obtained by the same technique.[31–33]
ANSII is not used as carrier protein in glycoconjugate
vaccines, however, it yields highly resolved SSNMR spec-
tra,[30] and approximately 74% of the resonances have been
assigned (unpublished data). We have thus selected ANSII as
a model system for this investigation. In the present work,
ANSII has been conjugated to the capsular polysaccharide
obtained from the meningococcal serogroup C (MenC). The
polysaccharide is a homopolymer of a2-9-linked N-acetyl-
neuraminic acid (NeuNAc) with partial O-acetylation at
position C7 and C8, and has been coupled to lysine residues
through an adipic acid linker. This work shows for the first
time that highly glycosylated proteins are now an affordable
target for structural characterization by SSNMR spectrosco-
py, and the pattern and the degree of conjugation can be
identified.
ANSII-MenC was investigated through solution and
solid-state NMR spectroscopy. The increase in hydrodynamic
volume of the ANSII after the conjugation with MenC
prevents the detection of the HN signals of the backbone by
standard solution 1H-15N TROSY-HSQC spectra. However,
such a spectrum of ANSII-MenC [U- 2H 13C 15N] displays
about 10 new HN signals in the region between 125 and
128 ppm on the 15N dimension. As already observed in the
case of PEGylation,[30] these signals correspond to the amide
groups generated by functionalization of the e-amino group of
lysines (Hz-Nz) with the MenC polysaccharide moieties. The
resonances of the non-functionalized lysines would appear at
very low 15N chemical shift values (around 30 ppm), but are
usually wiped out by exchange. On the contrary, when they
become amides, exchange is slowed down and the intrinsic
flexibility of the sidechain justifies the appearance of the Hz-
Nz cross-peaks. These signals are markers that can provide
direct information on the number of lysine residues involved
in the formation of new bonds with the MenC polysaccharide.
However, the assignment of each Hz-Nz couple to the
corresponding H-N of the backbone is a difficult task because
of the high overlap between Hz-Nz signals, and the lack of
connections between the two H-N couples across the side
chain. For the solid-state NMR investigation, ANSII (either
free or its MenC conjugate) was freeze-dried, packed into the
magic-angle spinning (MAS) rotors, then rehydrated to
restore the resolution.[30,34–36] The spectra collected on the
pelleted ANSII-MenC conjugate (Figure 2) are largely super-
imposable to those of the native and PEGylated forms of the
enzyme (see Figure S2 in the Sup-
porting Information) making pos-
sible the assessment of the preser-
vation of the protein fold after
conjugation with the MenC poly-
saccharide.[37–40] The resonances of
the protein residues were easily
reassigned starting from the assign-
ment of the native form of ANSII,
by using a carbon-detection
approach (Figure S3).[41] However,
the spectral overlap due to the
large number of protein resonan-
ces does not allow for straightfor-
ward identification of the lysine resonances. Therefore,
selective labeling with 1H, 13C, 15N lysine residues was applied
in an otherwise U-2H, NAC, NAN sample of ANSII, hereon [U-
2H, Lys-1H, 13C, 15N]. Assignment of 19 out of 22 lysine side-
chains of free and functionalized ANSII was achieved
through such a combination of solution and solid-state
NMR spectra (see the Supporting Information for details).
The three unassigned lysine residues (K44, K51 and K229) are
all solvent-exposed. Two spin systems could be identified in
the SSNMR spectra, while the third is probably lost because
of overlap.
The evaluation of the conjugation pattern was achieved by
integrating solution and solid-state NMR data. The Hz-Nz
cross-peaks corresponding to seven lysine residues could be
assigned in the 2D 1H-15N TROSY-HSQC (Figure 3b, top).
The intensity of the signals was used as a parameter to
evaluate the functionalization degree, although the signal
overlapping and the different dynamics of each lysine residue
do not make possible a precise quantitative measurement. In
this respect, the high signal intensity of K251, K101 and K273
is consistent with a high degree of conjugation, while for
K208, K218, K273 and K310, the lower signal intensity
indicates a lower derivatization. Complementary information
has been obtained from the analysis of the changes in the
Figure 2. 2D 13C-13C DARR solid-state NMR spectra of ANSII-MenC
acquired at 850 MHz and 290 K (mixing time 50 ms).
Figure 1. Schematic representation of the polydispersity in the population of ANSII-MenC conjugates.
The steric hindrance (represented by red curves) of the already bound polysaccharide chains prevents
further conjugation of the surrounding lysine residues.
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relative intensity of the cross-peaks correlating the Ca and the
Ce of the lysine side chains in the 2D
13C-13C dipolar-aided
rotary resonance (DARR) of the free and conjugated protein
(Figure 3b, bottom). In particular, we have observed remark-
able differences in the signal intensity among different groups
of resonances in the spectrum of ANSII-MenC (Figure 3b,
bottom). The disappearance of the Ca-Ce cross-peaks in the
spectra of the conjugated protein can be taken as a proof of an
extensive conjugation of the lysines. A complete disappear-
ance of the Ca-Ce cross-peak was observed for two solvent-
exposed unassigned lysines (belonging to K44 and/or K51
and/or K229), and for K273. Also, the signals of residues K65,
K71, K101, K161, K208, K218, K235, K251, K284 and K336
exhibit a decrease in signal intensity. However, the corre-
sponding cross-peaks are still visible in the spectrum of the
conjugated protein, indicating the presence of a significant
amount of unreacted residue (Figure 3b). Conversely, for the
residues K93, K94, K126, K129, K184, K194, K323 bearing no
solvent exposed Nz the decrease in intensity is negligible as
expected for non-conjugated lysines.
For better evaluation of the conjugation degree, the
information provided by solution and solid-state NMR
spectroscopy is summarized in a simple graph reporting the
relative signal intensity in the 13C-13C DARR and 1H-15N
TROSY-HSQC (Figure 3a). The analysis of the conjugation
degree obtained by combining the solution and solid-state
data is summarized in Figure 3c where the lysines are
represented as spheres and color-coded from dark red
(highly conjugated) to yellow (poorly conjugated). The non-
conjugated lysines are represented as black spheres.
In conclusion, solid-state NMR spectra of glycosylated
proteins showing an extremely high quality were obtained,
Figure 3. a) Relative signal intensities of Hz-Nz cross-peaks in the 2D
1H-15N TROSY-HSQC versus the relative signal intensities of the Ca-Ce cross-
peaks in 2D 13C-13C DARR of ANSII-MenC. The Hz-Nz cross-peak intensities have been related to the intensity of the Hz-Nz of K251, that is the
most intense, while the Ca- Ce peak intensities have been related to the intensity of the Ca- Ce cross-peaks of K126 that is the most intense and
isolated. The stars indicate the two spin systems for which the assignment is missing. b) Enlarged region of the 2D 1H-15N TROSY-HSQC of
ANSII-MenC acquired at 950 MHz, 310 K (top). Enlargement of the region of the 2D 13C-13C DARR spectrum of the ANSII-MenC displaying the
correlation between the Ca and the Ce of the lysine sidechains (bottom). The assignment of each lysine is reported in the Figure. The stars
indicate the two spin systems for which the assignment is missing. c) Surface representation of ANSII (PDB code: 3ECA) with the lysine residue
color-coded according to the degree of conjugation, from dark red (highly conjugated) to yellow (poorly conjugated). The non-conjugated lysines
are represented as black spheres.
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making it possible to confirm the preservation of the protein
fold and to achieve a residue-specific assignment of the
spectral perturbations that occur upon glycosylation. A
simple comparison of patterns of the Hz-Nz and Ca-Ce
cross-peaks, respectively in solution and solid state, can be
used to assess the preservation of the saccharide conjugation
degree at the protein sites, for instance after major changes in
the production process of the glycoconjugate vaccines. We
have here applied a strategy that is based on a combination of
solution and solid-state NMR experiments, which permits the
identification of the residues bearing the polysaccharide chain
and provides semi-quantitative information on the conjuga-
tion degree obtained by random chemical coupling. The
traditional strategy based on the generation of several single
point mutants of a protein to assign a specific amino acid may
be risky under this circumstance to assign the single lysines
and to evaluate their degree of conjugation, since the
functionalization of a lysine may sterically hinder nearby
lysine residues (Figure 1). The present approach allowed us to
assign 19 lysines, to identify two additional spin systems while
one is still missing or in overlap, without altering the reaction
propensity of any of the lysines. The characterization of large
polysaccharide–protein conjugates and highly glycosylated
proteins is still a challenge in structural biology and an
important goal for the development of vaccines and biologics,
and this protocol has the possibility to provide key informa-
tion for rational design of novel products with improved
efficacy.
Experimental Section
Preparation of ANSII-MenC conjugates is described in the
Supporting Information.
Solution NMR spectra were recorded at 310 K on Bruker
AVANCEIII-HD NMR spectrometers operating at 900 and
950MHz 1H larmor frequency, equipped with triple resonance cryo-
probes (see the Supporting Information). Protein samples were in
water buffered solution [20 mm sodium phosphate, pH 7.5, 0.02%
NaN3, 0.1 mgmL
@1 protease inhibitors (Pefabloc)].
SSNMR spectra were acquired on a Bruker AvanceIII spectrom-
eter operating at 800 MHz (Bruker 3.2 mm Efree NCH probehead)
or on a Bruker Avance III spectrometer operating at 850 MHz
(Bruker 3.2 mmNCHDVT probehead). All spectra were recorded at
14 kHz MAS frequency and the sample temperature was kept at
290 K.
Samples of freeze-dried free ANSII (U- 2H, Lys-1H, 13C, 15N ca.
10 mg of material) and ANSII-MenC (U-13C-15N ca. 14 mg of
material; U-2H, Lys-1H, 13C, 15N ca. 5 mg of material) were packed
into Bruker 3.2 mm zirconia rotors, then rehydrated until the
resolution of the 13C 1D SSNMR spectrum stopped chang-
ing.[30, 34–36,42–44] Standard 13C-detected two-dimensional spectra [13C-
13C DARR,[45,46] 15N-13C NCA,[47] 15N-13C NCO[48]] were acquired
according to reference.[49] These experiments last around 5 and
10 days for samples of free ANSII and ANSII-MenC, respectively. 1H
decoupling was set to 80 kHz using the swept-frequency two-pulse
phase modulation scheme[50] and the optimal interscan delay was
found to be 2.2 s.
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